The mechanisms mediating ICI resistance are not well established, but they include CD8+ T-cell dysfunction/exhaustion, tumor-cell antigen presentation defects, and the accumulation of immunosuppressive myeloid cell populations in the tumor microenvironment (TME; refs. 5–7). This evidence concerns the gene CD8A and neoplasm.